|
|
Volumn 345, Issue 2, 2014, Pages 150-152
|
|
Role of chronic inflammation in cancers of the gastrointestinal system and the liver: Where we are now
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CHEMOKINE;
CYCLOOXYGENASE 2 INHIBITOR;
CYTOKINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREBIOTIC AGENT;
PROBIOTIC AGENT;
SYNBIOTIC AGENT;
CANCER RISK;
CANCER STEM CELL;
CHEMOPROPHYLAXIS;
CHRONIC INFLAMMATION;
CHRONIC PANCREATITIS;
COLON CANCER;
COLON CARCINOGENESIS;
DIGESTIVE SYSTEM CANCER;
DISEASE ASSOCIATION;
DISEASE COURSE;
EPITHELIAL MESENCHYMAL TRANSITION;
ESOPHAGITIS;
GALLBLADDER CANCER;
GASTROESOPHAGEAL REFLUX;
HEPATITIS B;
HEPATITIS C;
HUMAN;
LIVER CANCER;
LIVER CARCINOGENESIS;
LIVER CELL CARCINOMA;
MALIGNANT TRANSFORMATION;
NONALCOHOLIC FATTY LIVER;
NONHUMAN;
PANCREAS CANCER;
PRIORITY JOURNAL;
PROGNOSIS;
SHORT SURVEY;
STOMACH CANCER;
STOMACH CARCINOGENESIS;
TUMOR MICROENVIRONMENT;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
ANTINEOPLASTIC AGENTS;
CELL TRANSFORMATION, NEOPLASTIC;
CHRONIC DISEASE;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
INFLAMMATION;
INFLAMMATION MEDIATORS;
LIVER NEOPLASMS;
PROGNOSIS;
RISK FACTORS;
SIGNAL TRANSDUCTION;
|
|
EID: 84896726118
PISSN: 03043835
EISSN: 18727980
Source Type: Journal
DOI: 10.1016/j.canlet.2013.10.013 Document Type: Review |
|
Times cited : (15)
|
|
References (9)
|
